TheraSphere for liver cancer before market in Japan
Part of Cancer, Digestive system clinical trials.
This trial tests a treatment called TheraSphere for people with liver cancer that hasn't responded to standard care or can't have it. TheraSphere uses tiny radioactive beads to target tumors in the liver, and this study is being done to get it approved in Japan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have liver cancer that is primary (started in the liver) or secondary (spread from elsewhere), as shown by a scan or biopsy
- Standard treatments have failed or you are not eligible for them, as decided by a team of doctors
- Your cancer is mostly in the liver, and you are expected to live at least 3 more months
- You are in good enough health to be up and around (able to care for yourself), with a score of 0 or 1 on a standard scale
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment using tiny radioactive beads (TheraSphere) to target and destroy liver tumors in people with early-stage liver cancer. It aims to confirm the safety and effectiveness of a new way to plan the treatment.
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors through a tube. It is for people with one or a few small liver tumors that cannot be removed with surgery or destroyed with heat or cold. The goal is to shrink or control the tumors with fewer side effects.
This trial tests a targeted internal radiation treatment for people with liver cancer (HCC) that is too widespread for surgery and goes beyond the up-to-7 criteria. It aims to see if this therapy can safely and effectively treat tumors that are all located in a specific area of the liver.
This Phase 2 trial tests TheraSphere® (a Y-90 radiation treatment delivered to the liver) combined with standard systemic therapy in people with high-risk hepatocellular carcinoma (HCC). It aims to shrink tumors and improve outcomes for people whose liver cancer is at higher risk to worsen.
This trial tests an affordable, made-in-India microsphere treatment for liver cancer that cannot be removed by surgery. The microspheres are tiny beads that can be injected into the liver to deliver radiation directly to the tumor, which may help control the cancer.
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors to shrink them, which may help patients become eligible for a liver transplant or surgery. It is for people with liver cancer that has not spread outside the liver.
Hear when a new Liver Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.